Merck & Co., Inc. (BIT:1MRKX)

Italy flag Italy · Delayed Price · Currency is EUR
68.90
+1.10 (1.62%)
Last updated: Jul 22, 2025
1.62%
Market Cap174.60B
Revenue (ttm)59.14B
Net Income (ttm)16.13B
Shares Outn/a
EPS (ttm)6.36
PE Ratio10.82
Forward PE9.13
Dividend2.22 (3.18%)
Ex-Dividend DateMar 14, 2025
Volume60
Average Volume165
Open69.00
Previous Close67.80
Day's Range68.90 - 69.50
52-Week Range65.40 - 124.20
Betan/a
RSI46.47
Earnings DateJul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Industry Pharmaceutical Preparations
Founded 1891
Employees 75,000
Stock Exchange Borsa Italiana
Ticker Symbol 1MRKX
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.